ישראל - עברית - Ministry of Health

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 25 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

ישראל - עברית - Ministry of Health

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 25 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

ישראל - עברית - Ministry of Health

neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 50 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.

ישראל - עברית - Ministry of Health

neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 100 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.

ישראל - עברית - Ministry of Health

neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 150 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.

ישראל - עברית - Ministry of Health

neopharm ltd, israel - lacosamide - טבליות מצופות פילם - lacosamide 200 mg - lacosamide - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.

ישראל - עברית - Ministry of Health

neopharm (israel)1996 ltd - hop cones dry extract; valerian root dry extract - טבליות מצופות פילם - hop cones dry extract 42 mg; valerian root dry extract 187.5 mg - valerian - valerian - herbal medicinal product for problems falling asleep and staying asleep, as well as restless sleep.

ישראל - עברית - Ministry of Health

neopharm ltd, israel - tetrabenazine - טבליה - tetrabenazine 25 mg - tetrabenazine - tetrabenazine - movement disorders, associated with organic central nervous system conditions, e.g. huntington's chorea, hemiballismus and senile chorea.moderate to severe tardive dyskinesia, which is disabling and/or socially embanassing. the condition should be persistent despite a switch to atypical antipsychotic medication and/or reduction in dosage of antipsychotic medication, when withdrawal of antipsychotic medication is not a realistic option.

ישראל - עברית - Ministry of Health

neopharm ltd - fluorouracil; salicylic acid - תמיסה - salicylic acid 10 g / 100 g; fluorouracil 0.5 g / 100 g - wart and anti-corn preparations - common warts ( special form : plantar warts, on areas of the sole of the foot that are subjected to pressure), plane juvenile warts of the extremities.

ישראל - עברית - Ministry of Health

neopharm (israel) 1996 ltd - hawthorn leaf and flower native extract; hop native extract; passion flower howthorn berries (2.8:1) native extract; valerian native extract - דרז'ה - valerian native extract 67.5 mg; hop native extract 29.4 mg; passion flower howthorn berries (2.8:1) native extract 81 mg; hawthorn leaf and flower native extract 81 mg - other hypnotics and sedatives - sedative, anxiety and tension states, insomnia.